Stock A222040 COSMAX NBT, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Cosmax Nbt, Inc.

Equities

A222040

KR7222040008

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-21 pm EDT 		5-day change 1st Jan Change
3,855 KRW -0.64% Intraday chart for Cosmax Nbt, Inc. -14.33% -39.95%
2023 Tranche Update on Cosmax Nbt, Inc.'s Equity Buyback Plan announced on June 27, 2023. CI
2023 Tranche Update on Cosmax Nbt, Inc.'s Equity Buyback Plan announced on June 27, 2023. CI

Strengths

  • Its low valuation, with P/E ratio at 5.16 and 3.81 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The stock, which is currently worth 2024 to 212.41 times its sales, is clearly overvalued in comparison with peers.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company does not generate enough profits, which is an alarming weak point.
  • The group shows a rather high level of debt in proportion to its EBITDA.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Food Processing

1st Jan change Capi. Investor Rating ESG Refinitiv
COSMAX NBT, INC. Stock Cosmax Nbt, Inc.
-39.95% 58.01M -
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+15.92% 8.35B
D+
BELLRING BRANDS, INC. Stock BellRing Brands, Inc.
+3.37% 7.62B
C-
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
+1.49% 6.01B -
THE SIMPLY GOOD FOODS COMPANY Stock The Simply Good Foods Company
-5.33% 3.75B
B-
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-7.57% 3.7B
D
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
-2.94% 1.34B - -
HERBALIFE LTD. Stock Herbalife Ltd.
-26.08% 1.13B
B+
SIRIO PHARMA CO., LTD. Stock Sirio Pharma Co., Ltd.
+14.95% 992M -
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-9.40% 925M
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. A222040 Stock
  4. Ratings Cosmax Nbt, Inc.